Provides certain controls over prescription drug costs by imposing transparency, oversight and accountability requirements on commercial insurers and their pharmacy benefit managers.
Provides an insurer would not impose prior authorization requirements for any service ordered by an in-network primary care provider.
Provides an insurer would not impose prior authorization requirements for any service ordered by an in-network primary care provider.
Prohibits an insurer from imposing a requirement of prior authorization for any admission, item, service, treatment, test, exam, study, procedure, or any generic or brand name prescription drug ordered by a primary care provider.
Prohibits an insurer from imposing a requirement of prior authorization for any admission, item, service, treatment, test, exam, study, procedure or any generic or brand name prescription drug ordered by a primary care provider
Would promote transparency and accountability in the use of artificial intelligence by health insurers to manage coverage and claims.
Promotes transparency and accountability in the use of artificial intelligence by health insurers to manage coverage and claims.
Requires that the department of human services and the department of behavioral healthcare, developmental disabilities and hospitals provide forecasted costs reflecting the recommended rate review on a monthly basis.